How many Tulisokibart clinical trials are there?

13 Tulisokibart clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 5 are actively recruiting participants. 4 are marked completed.

Are Tulisokibart clinical trials recruiting in 2026?

Yes — 5 Tulisokibart trials are actively recruiting in 2026, with 150 U.S. sites across 35 states. See the recruiting trials and the per-state site list further down this page.

What conditions is Tulisokibart being studied for?

Tulisokibart is being studied for Ulcerative Colitis, Colitis, Ulcerative, Crohn Disease, Healthy, Diffuse Cutaneous Systemic Sclerosis and 6 more. The trials are grouped by indication on this page.

What phase is Tulisokibart in?

Tulisokibart clinical trials span 3 Phase 3, 7 Phase 2, 3 Phase 1. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.

Who sponsors Tulisokibart clinical trials?

The lead sponsor across the most Tulisokibart trials is Merck Sharp & Dohme LLC, with 1 additional lead sponsor listed in the data. Each trial row links to the full study detail page including sponsor information.

Tulisokibart Clinical Trials (2026): 13 Studies for Ulcerative Colitis & Colitis, Ulcerative

Creator: Hipa.ai Research
Published: 2026-05-12T16:53:24.827Z

Hipa.ai Research · Source: ClinicalTrials.gov / AACT

Synced daily from ClinicalTrials.gov via AACT. Last sync: June 12, 2026.

13 Tulisokibart clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 10 indications (including Ulcerative Colitis & Colitis, Ulcerative) and 5,209 total planned enrollment. 3 Phase 3 Tulisokibart trials and 7 Phase 2 are listed. 5 Tulisokibart clinical trials are actively recruiting at 150 U.S. sites across 35 states. Most recent activity: NCT06651281 (Dec 2037).

Where to Participate: All Tulisokibart Trial Sites in the U.S. (150 sites across 35 states)

Every actively recruiting Tulisokibarttrial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.

State	Facility	City	Trial	Map
AL	Digestive Health Specialists ( Site 5064)	Dothan36301	NCT06430801	Map
AZ	AARA Clinical Research - Arizona Arthritis & Rheumatology Associates - Chandler ( Site 0036)	Chandler85225	NCT07133633	Map
AZ	AARA Clinical Research - Arizona Arthritis & Rheumatology Associates - Flagstaff ( Site 0021)	Flagstaff86001	NCT07133633	Map
AZ	Arizona Arthritis & Rheumatology Associates, P.C. - Gilbert ( Site 0022)	Gilbert85297	NCT07133633	Map
AZ	AARA Arizona Arthritis & Rheumatology Associates, P.C. - Glendale ( Site 0056)	Glendale85306	NCT07133633	Map
AZ	Arizona Arthritis & Rheumatology Associates, P.C. ( Site 1018)	Glendale85306-9802	NCT07176390	Map
AZ	AARA Clinical Research - Arizona Arthritis & Rheumatology Associates - Mesa ( Site 1033)	Mesa85210	NCT07176390	Map
AZ	Arizona Arthritis & Rheumatology Associates, P.C. ( Site 5117)	Sun City85351	NCT07486960	Map
AZ	GI Alliance - Sun City ( Site 5118)	Sun City85351	NCT06430801	Map
AZ	Arizona Arthritis & Rheumatology Associates, P.C. - Tucson ( Site 0025)	Tucson85704-1140	NCT07133633	Map
AZ	Arizona Arthritis & Rheumatology Associates, P.C. - Tucson ( Site 5120)	Tucson85704-1140	NCT07486960	Map
AZ	University of Arizona Clinical and Translational Sciences Research Center ( Site 5111)	Tucson85724	NCT06430801	Map
AR	University of Arkansas for Medical Sciences ( Site 5147)	Little Rock72205	NCT06430801	Map
CA	Clinnova Research ( Site 5110)	Anaheim92805	NCT06430801	Map
CA	TriWest Research Associates - Chula Vista ( Site 0013)	Chula Vista91910	NCT07133633	Map
CA	Southern California Research Center ( Site 5044)	Coronado92118	NCT06430801	Map
CA	Providence Medical Foundation ( Site 0049)	Fullerton92835	NCT07133633	Map
CA	Newport Huntington Medical Group ( Site 0005)	Huntington Beach92648	NCT07133633	Map
CA	Arthritis & Osteoporosis Medical Center - La Palma ( Site 1024)	La Palma90623	NCT07176390	Map
CA	Om Research LLC ( Site 5038)	Lancaster93534	NCT06430801	Map
CA	Cedars Sinai Medical Center ( Site 5080)	Los Angeles90048	NCT06430801	Map
CA	UCLA Clinical & Translational Research Center (CTRC) ( Site 5116)	Los Angeles90095	NCT06430801	Map
CA	University of California, Irvine (UCI) Health - UC Irvine Medical Center ( Site 5128)	Orange92868	NCT06430801	Map
CA	Om Research LLC ( Site 5045)	Oxnard93030	NCT06430801	Map
CA	Medvin Clinical Research - Riverside ( Site 5115)	Riverside92508	NCT07486960	Map
CA	Clinical Applications Laboratories ( Site 5123)	San Diego92103	NCT06430801	Map
CA	Cohen Medical Centers ( Site 0034)	Thousand Oaks91360-3967	NCT07133633	Map
CA	Cohen Medical Centers ( Site 5111)	Thousand Oaks91360	NCT07486960	Map
CA	Medvin Clinical Research - Tujunga ( Site 5113)	Tujunga91042	NCT07486960	Map
CA	Inland Rheumatology Clinical Trials, Inc. ( Site 0002)	Upland91786	NCT07133633	Map
CO	University of Colorado Anschutz Medical Campus-Division of Gastroenterology and Hepatology ( Site 5026)	Aurora80045	NCT06430801	Map
CO	Peak Gastroenterology Associates ( Site 5023)	Colorado Springs80907	NCT06430801	Map
CO	South Denver Gastroenterology, PC ( Site 5132)	Englewood80113	NCT06430801	Map
CO	Tekton Research, LLC. ( Site 1008)	Fort Collins80528	NCT07176390	Map
CO	Rocky Mountain Gastroenterology ( Site 5082)	Lakewood80228	NCT06430801	Map
CT	Connecticut Clinical Research Institute ( Site 0297)	Bristol06010	NCT06651281	Map
CT	Yale University School of Medicine-Digestive Disease ( Site 5019)	New Haven06510	NCT06430801	Map
DC	Emerson Clinical Research Institute ( Site 5051)	Washington D.C.20009	NCT06430801	Map
FL	Arthritis and Rheumatic Disease Specialties ( Site 0016)	Aventura33180	NCT07133633	Map
FL	Arthritis and Rheumatic Disease Specialties ( Site 5105)	Aventura33180	NCT07486960	Map
FL	Bay Area Arthritis and Osteoporosis ( Site 0041)	Brandon33511	NCT07133633	Map
FL	GNP Research - Hollywood ( Site 0020)	Cooper City33024	NCT07133633	Map
FL	Covenant Metabolic Specialists, LLC ( Site 5150)	Fort Myers33912	NCT06430801	Map
FL	Sweet Hope Research Specialty, Inc ( Site 1015)	Hialeah33016	NCT07176390	Map
FL	Nature Coast Clinical Research - Inverness ( Site 5042)	Inverness34452	NCT06430801	Map
FL	Atlantic Medical Research ( Site 5073)	Margate33063	NCT06430801	Map
FL	Sanchez Clinical Research ( Site 5144)	Miami33157	NCT06430801	Map
FL	AdventHealth Orlando ( Site 5131)	Orlando32803	NCT06430801	Map
FL	Endoscopic Research Inc ( Site 5061)	Orlando32803	NCT06430801	Map
FL	HMD Research LLC ( Site 1016)	Orlando32819	NCT07176390	Map
FL	Innovation Medical Research Center ( Site 0012)	Palmetto Bay33157	NCT07133633	Map
FL	International Center for Research ( Site 5124)	Tampa33614	NCT07486960	Map
FL	USF Health Carol and Frank Morsani Center for Advanced Healthcare ( Site 5039)	Tampa33612	NCT06430801	Map
FL	Covenant Metabolic Specialists, LLC ( Site 5143)	University Park34201	NCT06430801	Map
GA	Morehouse School Of Medicine ( Site 5071)	Atlanta30310	NCT06430801	Map
GA	Gastroenterology Associates of Central Georgia ( Site 5048)	Macon31201	NCT06430801	Map
IL	Chicago Arthritis & Regenerative Medicine ( Site 0042)	Chicago60661	NCT07133633	Map
IL	University of Chicago Medical Center ( Site 5066)	Chicago60637	NCT06430801	Map
IL	Endeavor Health ( Site 5018)	Evanston60201	NCT06430801	Map
IL	GI ALLIANCE - GURNEE ( Site 5003)	Gurnee60031	NCT06430801	Map
IL	Greater Chicago Specialty Physicians - Orland Park ( Site 1043)	Orland Park60467	NCT07176390	Map
IL	Willow Rheumatology and Wellness, PLLC ( Site 0035)	Willowbrook60527	NCT07133633	Map
IN	Indiana University Health University Hospital ( Site 5022)	Indianapolis46202	NCT06430801	Map
IA	Iowa Digestive Disease Center ( Site 5007)	Clive50325	NCT06430801	Map
KS	University of Kansas Medical Center ( Site 5091)	Kansas City66160	NCT06430801	Map
KS	Cotton O'Neil Digestive Health Center ( Site 5033)	Topeka66606	NCT06430801	Map
KY	University of Louisville Hospital ( Site 5120)	Louisville40202	NCT06430801	Map
MD	Walter Reed National Military Medical Center ( Site 5006)	Bethesda20889	NCT06430801	Map
MD	Arthritis and Rheumatism Associates - Rockville ( Site 0019)	Rockville20850	NCT07133633	Map
MD	Arthritis and Rheumatism Associates - Rockville ( Site 5127)	Rockville20850	NCT07486960	Map
MA	Massachusetts General Hospital-Crohn's and Colitis Center ( Site 5037)	Boston02114	NCT06430801	Map
MI	University of Michigan ( Site 5060)	Ann Arbor48109	NCT06430801	Map
MI	Clinical Research Institute of Michigan, LLC ( Site 5002)	Clinton Township48038	NCT06430801	Map
MI	AA Medical Research Center ( Site 1027)	Grand Blanc48439	NCT07176390	Map
MI	St. Joseph Mercy Hospital - Huron Gastroenterology Associates ( Site 0287)	Ypsilanti48197	NCT06651281	Map
MN	Mayo Clinic in Rochester, Minnesota ( Site 5024)	Rochester55905	NCT06430801	Map
MO	Kansas City Physician Partners ( Site 0027)	Kansas City64111	NCT07133633	Map
MO	Kansas City Physician Partners ( Site 1032)	Kansas City64111	NCT07176390	Map
MO	Kansas City Physician Partners ( Site 5119)	Kansas City64111	NCT07486960	Map
MO	Mid-America GI Clinical Research ( Site 5130)	Kansas City64111	NCT06430801	Map
MO	BVL Research - Kansas ( Site 0292)	Liberty64068	NCT06651281	Map
MO	BVL Research - Kansas ( Site 5099)	Liberty64068	NCT06430801	Map
MO	Velocity Clinical Research - West County Rheumatology, St. Louis ( Site 0038)	St Louis63131	NCT07133633	Map
MO	Washington University School of Medicine ( Site 5058)	St Louis63110	NCT06430801	Map
NE	Physician Research Collaboration, LLC ( Site 0057)	Lincoln68516-5497	NCT07133633	Map
NE	Physician Research Collaboration, LLC ( Site 1002)	Lincoln68516	NCT07176390	Map
NE	Physician Research Collaboration, LLC ( Site 5102)	Lincoln68516	NCT07486960	Map
NJ	HMH Justice Marie Garibaldi Medical Plaza ( Site 5072)	Hackensack07601	NCT06430801	Map
NM	Inspire Santa Fe Medical Group ( Site 0011)	Santa Fe87505	NCT07133633	Map
NY	Northwell Health Physician Partners Center for Advanced IBD Care ( Site 5017)	Great Neck11021	NCT06430801	Map
NY	New York Gastroenterology Associates ( Site 0253)	New York10075	NCT06651281	Map
NY	New York Gastroenterology Associates ( Site 5013)	New York10075	NCT06430801	Map
NY	NYU Langone Health - Inflammatory Bowel Disease Center (IBD) ( Site 5078)	New York10016	NCT06430801	Map
NY	Weill Cornell Medical College, New-York Presbyterian Hospital ( Site 5079)	New York10065	NCT06430801	Map
NY	Northwell Mather Hospital ( Site 5138)	Port Jefferson11777	NCT06430801	Map
NC	University of North Carolina Medical Center ( Site 5034)	Chapel Hill27514	NCT06430801	Map
NC	Atrium Health Gastroenterology MMP ( Site 5105)	Charlotte28204	NCT06430801	Map
NC	Joint and Muscle Research Institute ( Site 5108)	Charlotte28204	NCT07486960	Map
OH	Great Lakes Gastroenterology Research, LLC ( Site 5016)	Mentor44060	NCT06430801	Map
OK	Digestive Disease Specialists Inc. ( Site 5117)	Oklahoma City73114	NCT06430801	Map
OR	Oregon Health & Science University ( Site 0059)	Portland97239	NCT07133633	Map
PA	Altoona Center for Clinical Research ( Site 0004)	Duncansville16635	NCT07133633	Map
PA	altoona center for clinical research ( Site 1005)	Duncansville16635	NCT07176390	Map
PA	Altoona Center for Clinical Research ( Site 5110)	Duncansville16635	NCT07486960	Map
PA	Penn State University Milton S. Hershey Medical Center ( Site 5102)	Hershey17033	NCT06430801	Map
PA	Hospital of the University of Pennsylvania ( Site 5134)	Philadelphia19104	NCT07486960	Map
PA	Perelman Center for Advanced Medicine ( Site 0060)	Philadelphia19104	NCT07133633	Map
PA	Thomas Jefferson University Hospital ( Site 5133)	Philadelphia19107	NCT06430801	Map
PA	Frontier Clinical Research, LLC ( Site 5098)	Uniontown15401	NCT06430801	Map
PA	Rheumatology Specialty Center ( Site 1030)	Willow Grove19090	NCT07176390	Map
RI	University Gastroenterology - Providence - West River Street ( Site 5057)	Providence02904	NCT06430801	Map
SC	Articularis Healthcare Group dba: Low Country Rheumatology ( Site 5128)	Summerville29486	NCT07486960	Map
SD	Sanford USD Medical Center ( Site 5129)	Sioux Falls57105	NCT06430801	Map
TN	AARA Clinical Research - Murfreesboro Medical Clinic ( Site 0029)	Murfreesboro37128	NCT07133633	Map
TN	AARA Clinical Research - Murfreesboro Medical Clinic ( Site 1034)	Murfreesboro37128	NCT07176390	Map
TN	Quality Medical Research ( Site 5114)	Nashville37211	NCT06430801	Map
TN	Vanderbilt Inflammatory Bowel Disease Clinic ( Site 5049)	Nashville37204	NCT06430801	Map
TX	Rheumatology Associates ( Site 0055)	Arlington76012	NCT07133633	Map
TX	Rheumatology Associates ( Site 1026)	Arlington76012	NCT07176390	Map
TX	Arthritis Care of Texas ( Site 0048)	Corpus Christi78415	NCT07133633	Map
TX	Baylor University Medical Center ( Site 5031)	Dallas75246	NCT06430801	Map
TX	Epic Medical Research - Mesquite ( Site 5153)	Denton76201	NCT06430801	Map
TX	Lone Star Arthritis & Rheumatology Associates, P.C. ( Site 0028)	Fort Worth76109	NCT07133633	Map
TX	GI Alliance - Digestive Health Associates of Texas - DHAT ( Site 0290)	Garland75044	NCT06651281	Map
TX	Baylor College of Medicine Medical Center ( Site 5020)	Houston77030	NCT06430801	Map
TX	Greater Houston Rheumatology ( Site 5103)	Houston77095	NCT07486960	Map
TX	Michael E. DeBakey VA Medical Center ( Site 5086)	Houston77030	NCT06430801	Map
TX	Provecta Research Network LLC ( Site 0054)	Houston77027	NCT07133633	Map
TX	AARA Clinical Research - Lone Star Arthritis and Rheumatology Associates - Irving ( Site 0032)	Irving75039	NCT07133633	Map
TX	Caprock Gastro Research ( Site 0293)	Lubbock79424	NCT06651281	Map
TX	Caprock Gastro Research ( Site 5077)	Lubbock79424	NCT06430801	Map
TX	GI Alliance - Lubbock ( Site 0288)	Lubbock79410	NCT06651281	Map
TX	GI Alliance - Lubbock ( Site 5012)	Lubbock79410	NCT06430801	Map
TX	GI Alliance: Mansfield ( Site 5015)	Mansfield76063	NCT06430801	Map
TX	Epic Medical Research ( Site 0061)	Red Oak75154	NCT07133633	Map
TX	Epic Medical Research ( Site 1004)	Red Oak75154	NCT07176390	Map
TX	Southern Star Research Institute ( Site 0299)	San Antonio78229	NCT06651281	Map
TX	Southern Star Research Institute ( Site 5000)	San Antonio78229	NCT06430801	Map
TX	GI Alliance - Southlake ( Site 0298)	Southlake76092-9167	NCT06651281	Map
TX	GI Alliance - Southlake ( Site 5109)	Southlake76092-9167	NCT06430801	Map
TX	Advanced Rheumatology of Houston - Woodlands ( Site 1000)	The Woodlands77382	NCT07176390	Map
TX	Advanced Rheumatology of Houston ( Site 0001)	The Woodlands77382	NCT07133633	Map
TX	DM Clinical Research - TRA ( Site 0010)	Tomball77375	NCT07133633	Map
TX	Tyler Research Institute ( Site 0294)	Tyler75701	NCT06651281	Map
TX	Tyler Research Institute ( Site 5001)	Tyler75701	NCT06430801	Map
VA	University of Virginia Health System ( Site 0291)	Charlottesville22908	NCT06651281	Map
VA	Richmond VA Medical Center ( Site 5021)	Richmond23249	NCT06430801	Map
WA	University of Washington ( Site 5115)	Seattle98195	NCT06430801	Map
WA	Washington Gastroenterology - Tacoma ( Site 0295)	Tacoma98405	NCT06651281	Map
WA	Washington Gastroenterology - Tacoma ( Site 5004)	Tacoma98405	NCT06430801	Map

Tulisokibart clinical trials at a glance: phase × recruitment status

Phase	recruiting	active not recruiting	completed	Total
P1		1	2	3
P2	3	2	2	7
P3	2	1		3

Recruiting Tulisokibart clinical trials (5)

Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).

NCT ID	Title	Phase	Indication	Enrollment	Started
NCT06651281	MK-7240-011Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)	P3	Crohn Disease	1,380	Nov 2024
NCT07133633	MK-7240A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)	P2	Radiographic Axial Spondyloarthritis	315	Sep 2025
NCT07486960	MK-7240-015Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015)	P2	Psoriatic Arthritis	140	Apr 2026
NCT06430801	MK-7240A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)	P3	Crohn's Disease	1,200	Jun 2024
NCT07176390	MK-7240A Clinical Study of Tulisokibart (MK-7240) to Treat Rheumatoid Arthritis (RA) (MK-7240-014)	P2	Arthritis, Rheumatoid	182	Oct 2025

Tulisokibart clinical trials by indication

Healthy (2)

NCT	Acronym	Phase	Status	Title
NCT07405177	MK-7240-009	P1	active not recruiting	A Study of MK-7240 in Healthy Participants (MK-7240-009)
NCT06575595	PK	P1	completed	Pharmacokinetic (PK) Characterization of Subcutaneous Tulisokibart (MK-7240-010)

Crohn Disease (2)

NCT	Acronym	Phase	Status	Title
NCT06651281	MK-7240-011	P3	recruiting	Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
NCT05013905	APOLLO-CD	P2	completed	A Phase 2a Safety and Efficacy Open-Label Study of Tulisokibart (MK-7240/PRA023) in Participants With Moderately to Severely Active Crohn's Disease (MK-7240-006)

Ulcerative Colitis (2)

NCT	Acronym	Phase	Status	Title
NCT06052059	MK-7240	P3	active not recruiting	A Study to Evaluate Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderately to Severely Active Ulcerative Colitis (MK-7240-001)
NCT04996797	ARTEMIS-UC	P2	completed	A Phase 2 Safety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Moderately to Severely Active Ulcerative Colitis (MK-7240-005)

Psoriatic Arthritis (1)

NCT	Acronym	Phase	Status	Title
NCT07486960	MK-7240-015	P2	recruiting	Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015)

Arthritis, Rheumatoid (1)

NCT	Acronym	Phase	Status	Title
NCT07176390	MK-7240	P2	recruiting	A Clinical Study of Tulisokibart (MK-7240) to Treat Rheumatoid Arthritis (RA) (MK-7240-014)

Radiographic Axial Spondyloarthritis (1)

NCT	Acronym	Phase	Status	Title
NCT07133633	MK-7240	P2	recruiting	A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)

Hidradenitis Suppurativa (1)

NCT	Acronym	Phase	Status	Title
NCT06956235	MK-7240-012	P2	active not recruiting	Study to Evaluate Tulisokibart for Hidradenitis Suppurativa (MK-7240-012)

Colitis, Ulcerative (1)

NCT	Acronym	Phase	Status	Title
NCT06829225	MK-7240	P1	completed	Single Dose Study of Tulisokibart (MK-7240) in Healthy Chinese Participants (MK-7240-002)

Crohn's Disease (1)

NCT	Acronym	Phase	Status	Title
NCT06430801	MK-7240	P3	recruiting	A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

Diffuse Cutaneous Systemic Sclerosis (1)

NCT	Acronym	Phase	Status	Title
NCT05270668	ATHENA-SSc-ILD	P2	active not recruiting	Phase 2 Safety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Systemic Sclerosis Associated With Interstitial Lung Disease (SSc-ILD) (MK-7240-007)

Tulisokibart pivotal trial highlights (Phase 2/3/4)

Phase-2/3/4 studies with named acronyms — the registration-grade trials most cited in label discussions and Wikipedia.

Acronym	NCT	Phase	Status	Indication	Enrollment	PubMed
MK-7240-011	NCT06651281	P3	recruiting	Crohn Disease	1,380	—
MK-7240	NCT06430801	P3	recruiting	Crohn's Disease	1,200	—
MK-7240	NCT06052059	P3	active not recruiting	Ulcerative Colitis	1,020	—
MK-7240	NCT07133633	P2	recruiting	Radiographic Axial Spondyloarthritis	315	—
MK-7240-015	NCT07486960	P2	recruiting	Psoriatic Arthritis	140	—
MK-7240	NCT07176390	P2	recruiting	Arthritis, Rheumatoid	182	—
ATHENA-SSc-ILD	NCT05270668	P2	active not recruiting	Diffuse Cutaneous Systemic Sclerosis	154	—
MK-7240-012	NCT06956235	P2	active not recruiting	Hidradenitis Suppurativa	147	—
ARTEMIS-UC	NCT04996797	P2	completed	Ulcerative Colitis	178	PMID 39321363
APOLLO-CD	NCT05013905	P2	completed	Crohn Disease	55	PMID 40456235

All Tulisokibart trials (13)

Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.

NCT ID	Acronym	Title	Phase	Status	Enrollment	Sponsor	Started
NCT06651281	MK-7240-011	Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)	P3	recruiting	1,380	Merck Sharp & Dohme LLC	Nov 2024
NCT07133633	MK-7240	A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)	P2	recruiting	315	Merck Sharp & Dohme LLC	Sep 2025
NCT07486960	MK-7240-015	Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015)	P2	recruiting	140	Merck Sharp & Dohme LLC	Apr 2026
NCT06430801	MK-7240	A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)	P3	recruiting	1,200	Merck Sharp & Dohme LLC	Jun 2024
NCT07176390	MK-7240	A Clinical Study of Tulisokibart (MK-7240) to Treat Rheumatoid Arthritis (RA) (MK-7240-014)	P2	recruiting	182	Merck Sharp & Dohme LLC	Oct 2025
NCT06052059	MK-7240	A Study to Evaluate Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderately to Severely Active Ulcerative Colitis (MK-7240-001)	P3	active not recruiting	1,020	Merck Sharp & Dohme LLC	Oct 2023
NCT05270668	ATHENA-SSc-ILD	Phase 2 Safety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Systemic Sclerosis Associated With Interstitial Lung Disease (SSc-ILD) (MK-7240-007)	P2	active not recruiting	154	Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)	Mar 2022
NCT06956235	MK-7240-012	Study to Evaluate Tulisokibart for Hidradenitis Suppurativa (MK-7240-012)	P2	active not recruiting	147	Merck Sharp & Dohme LLC	Jun 2025
NCT07405177	MK-7240-009	A Study of MK-7240 in Healthy Participants (MK-7240-009)	P1	active not recruiting	330	Merck Sharp & Dohme LLC	Mar 2026
NCT04996797	ARTEMIS-UC	A Phase 2 Safety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Moderately to Severely Active Ulcerative Colitis (MK-7240-005)	P2	completed	178	Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)	Jul 2021
NCT05013905	APOLLO-CD	A Phase 2a Safety and Efficacy Open-Label Study of Tulisokibart (MK-7240/PRA023) in Participants With Moderately to Severely Active Crohn's Disease (MK-7240-006)	P2	completed	55	Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)	Jul 2021
NCT06575595	PK	Pharmacokinetic (PK) Characterization of Subcutaneous Tulisokibart (MK-7240-010)	P1	completed	60	Merck Sharp & Dohme LLC	Sep 2024
NCT06829225	MK-7240	Single Dose Study of Tulisokibart (MK-7240) in Healthy Chinese Participants (MK-7240-002)	P1	completed	48	Merck Sharp & Dohme LLC	Jun 2024

Tulisokibart clinical trials: frequently asked questions

How many Tulisokibart clinical trials are there?: 13 Tulisokibart clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 5 are actively recruiting participants. 4 are marked completed.
Are Tulisokibart clinical trials recruiting in 2026?: Yes — 5 Tulisokibart trials are actively recruiting in 2026, with 150 U.S. sites across 35 states. See the recruiting trials and the per-state site list further down this page.
What conditions is Tulisokibart being studied for?: Tulisokibart is being studied for Ulcerative Colitis, Colitis, Ulcerative, Crohn Disease, Healthy, Diffuse Cutaneous Systemic Sclerosis and 6 more. The trials are grouped by indication on this page.
What phase is Tulisokibart in?: Tulisokibart clinical trials span 3 Phase 3, 7 Phase 2, 3 Phase 1. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.
Who sponsors Tulisokibart clinical trials?: The lead sponsor across the most Tulisokibart trials is Merck Sharp & Dohme LLC, with 1 additional lead sponsor listed in the data. Each trial row links to the full study detail page including sponsor information.

Sources and methodology

Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming Tulisokibartas an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.

Last refreshed June 12, 2026.

Related pages on Hipa.ai:

Tulisokibart overview Tulisokibart evidence & publications